Healthy Donor-Derived iPSCs-SomaxBio

Healthy Donor-Derived iPSCs

Catalog No.：

See Product Information

Specification：

1×10⁶ cells/vial

Storage Conditions：

Liquid nitrogen

Product Introduction：

Healthy Donor-Derived iPSCs are generated from peripheral blood mononuclear cells (PBMCs) of healthy donors (defined as individuals without known genetic diseases, chronic diseases, or tumor history) via non-integrating reprogramming method. Cultured in feeder-free, chemically defined iPSC maintenance medium, the cells can proliferate stably and exhibit morphological characteristics, cell phenotypes, and gene expression patterns similar to human embryonic stem cells (hESCs). Strict quality control confirms that the cells have a normal chromosomal karyotype, no exogenous gene integration, pluripotent differentiation potential into three germ layers, and a high positive rate of pluripotency marker expression.

Product Advantages

Provides ethical approval number with traceability

Provides international stem cell registry number for direct citation in publications

Low passage number with latest characterization report

Diverse cell types available (more than 20 options)

Validated by differentiation into various cells and organoids

One-on-one technical guidance to assist customers in successful cell culture

Specialized in iPSCs for over a decade, offering one-stop iPSC solutions

Operation Procedures and Precautions

After receiving the cells, observe and record any signs of thawing during transportation and the integrity of the cryovials.

Transfer to liquid nitrogen immediately; temporary storage at -80℃ is allowed, but prolonged storage is strictly prohibited.

Recommended recovery culture system for cryovials: 2 wells of a 6-well plate.

Application Scope

This product is for research use only and not for clinical treatment or other purposes.

Cell Characteristics

24h post-recovery (4X)

72h post-recovery (4X)

Product Information

Cell Type	Catalog No.	Source	Specification	International Stem Cell Registry Number
Research-grade iPSC Line - Male	JY01-012-1	29-year-old male	1×10⁶ cells/vial	GEMi001-A
	JY01-014-1	28-year-old male	1×10⁶ cells/vial	GEMi002-A
	JY01-160-1	25-year-old male	1×10⁶ cells/vial	GEMi005-A
	JY01-211-2	25-year-old male	1×10⁶ cells/vial	GEMi016-A
	JY01-212-1	26-year-old male	1×10⁶ cells/vial	GEMi017-A
	JY01-213-1	42-year-old male	1×10⁶ cells/vial	GEMi018-A
	JY01-215-1	32-year-old male	1×10⁶ cells/vial	GEMi020-A
	JY01-216-1	35-year-old male	1×10⁶ cells/vial	GEMi021-A
	JY01-217-1	34-year-old male	1×10⁶ cells/vial	GEMi022-A
	JY01-218-1	23-year-old male	1×10⁶ cells/vial	GEMi023-A
Research-grade iPSC Line - Female	JY01-135-1	24-year-old female	1×10⁶ cells/vial	GEMi004-A
	JY01-201-1	27-year-old female	1×10⁶ cells/vial	GEMi006-A
	JY01-202-1	25-year-old female	1×10⁶ cells/vial	GEMi007-A
	JY01-203-1	30-year-old female	1×10⁶ cells/vial	GEMi008-A
	JY01-206-1	25-year-old female	1×10⁶ cells/vial	GEMi011-A
	JY01-208-1	40-year-old female	1×10⁶ cells/vial	GEMi013-A
	JY01-209-1	50-year-old female	1×10⁶ cells/vial	GEMi014-A
	JY01-210-1	23-year-old female	1×10⁶ cells/vial	GEMi015-A
	JY01-046-3	28-year-old female	1×10⁶ cells/vial	GEMi026-A

iPSC Cell Products
Other Products

Healthy Donor-Derived iPSCs Disease Model iPSCs Fluorescently Labeled iPSCs (GFP/mCherry) NGN2-Stable iPSCs

Questions

When thawing and seeding iPSC cells, most of them are found to be in a single-cell morphology and hardly attach after 24 hours. What is the cause, and how should it be handled? Precautions for iPSC cell passaging Cells exhibit vacuolization. The significance of establishing iPSC lines from the blood of patients with rare diseases